Chemomab Therapeutics Ltd. (CMMB) income statement
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.19+0.05 (+4.39%)
Close on Nov 20, 2026Market cap $8.56MP/E 0.8Yield –
Chemomab Therapeutics Ltd. financial ratios
See a number that looks wrong?